文献速递睡眠呼吸障碍

阻塞性睡眠呼吸暂停患者自主减重干预的实用性试验(POWER)

Pragmatic trial of a self-directed intervention for weight loss in obstructive sleep apnea (POWER).
PubMed 文献 · Am J Respir Crit Care Med · 2026-10-30

POWER 试验在全美退伍军人事务站点纳入 696 例阻塞性睡眠呼吸暂停(OSA)且 BMI 30–45 kg/m² 的患者,随机比较基于糖尿病预防计划的自主生活方式干预与常规照护。12 个月时体重组间差异为 -1.1 kg(95%CI -2.0, -0.1;p=0.037),FOSQ 组间差异为 0.6 分(95%CI 0.2, 1.0;p=0.001),均未达到预设的 p=0.025 显著性阈值。

要点

  • 自主减重干预未显著改善 12 个月体重(p=0.037,未达 0.025 阈值)。
  • FOSQ 改善 0.6 分(p=0.001),但临床重要性有限。
  • 干预组 12 个月体重数据完整率 81.9%,对照组 83.6%。

核心结论

  • 在 OSA 合并肥胖患者中,自主生活方式干预未改善体重,睡眠相关生活质量改善的临床重要性有限。

研究设计与样本

  • 实用性随机对照试验,纳入 696 例 OSA 且 BMI 30–45 kg/m² 的患者,来自全美退伍军人事务站点。
  • 干预组接受基于糖尿病预防计划的自主干预(视频课程、阅读材料、定期教练提醒),对照组接受常规照护。
  • 共同主要结局为基线至随机后 12 个月 FOSQ 与临床体重(kg)的变化,显著性阈值设为 p=0.025。

主要发现

  • 12 个月体重:干预组未调整下降 2.1 kg(SD 6.8),对照组下降 0.9 kg(SD 5.9)。
  • 12 个月体重调整组间差异:-1.1 kg(95%CI -2.0, -0.1;p=0.037)。
  • 12 个月 FOSQ:干预组未调整改善 1.4 分(SD 2.7),对照组改善 0.9 分(SD 2.9)。
  • 12 个月 FOSQ 调整组间差异:0.6 分(95%CI 0.2, 1.0;p=0.001)。
  • 12 个月体重数据完整率:干预组 81.9%,对照组 83.6%;FOSQ 数据完整率:干预组 78.2%,对照组 90.5%。

临床怎么用

  • 自主生活方式干预不应作为 OSA 合并肥胖患者减重的主要策略。
  • 若采用该类干预,需告知患者体重改善可能有限。

局限性

  • 12 个月体重数据完整率干预组 81.9%、对照组 83.6%,FOSQ 数据完整率干预组 78.2%、对照组 90.5%,存在缺失数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Self-directed lifestyle interventions may improve access to weight loss care in obstructive sleep apnea (OSA), but effectiveness in routine practice is unknown. OBJECTIVE: Test whether a proactively delivered self-directed lifestyle intervention improves weight and sleep-related quality of life versus usual care. METHODS: POWER enrolled patients with OSA and body mass index of 30-45 kg/m2, recruited from Veteran Affairs (VA) sites nationwide, and randomized participants to a self-directed intervention based on the Diabetes Prevention Program with video-based sessions, readings, and regular coaching reminders or usual care. Co-primary outcomes were change in Functional Outcomes of Sleep Questionnaire (FOSQ) and clinical weight in kilograms (kg) from baseline to 12 months post-randomization. Given two primary outcomes, we defined significance at p = 0.025. MEASUREMENTS AND MAIN RESULTS: This trial randomized 696 participants. Mean age was 56.2 years (SD 12.2), with 19.7% identifying as female. Clinical weights at 12 months were available for 81.9% of intervention and 83.6% of control participants. Unadjusted weight declined 2.1 kg (SD 6.8) in intervention and 0.9 kg (SD 5.9) in control (adjusted between-group difference: -1.1 kg, 95%CI -2.0, -0.1; p = 0.037). FOSQ measures were available at 12 months for 78.2% of intervention and 90.5% of control participants. From baseline to 12 months, unadjusted FOSQ improved 1.4 (SD 2.7) points in intervention and 0.9 (SD 2.9) points in control (adjusted between-group difference: 0.6 points, 95%CI 0.2, 1.0; p = 0.001). CONCLUSION AND RELEVANCE: Among participants with OSA and obesity, a self-directed lifestyle intervention did not improve weight loss and led to improvements in sleep-related quality of life that are of limited clinical importance. TRIAL REGISTRATION: Clinicaltrials.gov NCT05104450, registered 10/19/2021.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Donovan LM, McDowell JA, Maskey P, et al. Pragmatic trial of a self-directed intervention for weight loss in obstructive sleep apnea (POWER). Am J Respir Crit Care Med. 2026. PMID: 42960868. doi:10.1093/ajrccm/aamag574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。